Strategies for delivery of rod-derived cone viability factor

Retina

Volumn 25, Issue 8 SUPPL., 2005, Pages

  Bennett, Jean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN; PROTEIN; RAPAMYCIN; ROD DERIVED CONE VIABILITY FACTOR; THIOREDOXIN; UNCLASSIFIED DRUG; ROD DERIVED CONE VIABILITY FACTOR, HUMAN; ROD-DERIVED CONE VIABILITY FACTOR, HUMAN;

CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; LENTIVIRUS VECTOR; MUELLER CELL; NONHUMAN; PARVOVIRUS VECTOR; PHOTORECEPTOR CELL; RETINA CELL; RETINA CONE; RETINITIS PIGMENTOSA; UPREGULATION; VIRUS CAPSID; ADENO ASSOCIATED VIRUS; ANIMAL; GENE VECTOR; GENETICS; METHODOLOGY; REVIEW;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RETINITIS PIGMENTOSA; THIOREDOXIN;

EID: 33644878148     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200512001-00020     Document Type: Conference Paper

References (2)

1. Leveillard T, Mohand-Said S, Lorentz O, et al. Identification and characterization of rod-derived cone viability factor. Nat Genet 2004;36:775-779.
2. Lebherz C, Auricchio A, Maguire AM, et al. Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum Gene Ther 2005;16:178-186.